RUNX1/ETO knockdown reduced CCND1 and CDK6 expression, with CCND1 transcript levels also being diminished in primary AML cells (Figures 5B, 5C, and S5B–S5D). The gene discussed is CDK6; the disease is acute myeloid leukemia.